CS logo
small CS logo
Tennessee Oncology PLLC- Centennial Medical Center

Nashville, Tennessee, United States
Oncologist in Nashville, Tennessee
250 25th Ave N #412, Nashville, TN 37203

About Tennessee Oncology PLLC- Centennial Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Tennessee Oncology PLLC- Centennial Medical Center


During the past decade, Tennessee Oncology PLLC- Centennial Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
1999-12-01
Completed
515
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
1999-11-01
2009-07-01
Completed
29
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
2000-11-20
2016-07-16
Completed
31
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer
2001-07-01
2013-11-01
Completed
63
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
2001-09-01
2001-09-01
Withdrawn
0
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381

Rows per page:

1–100 of 224

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Novartis Pharmaceuticals" with 3 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Akeso" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tennessee Oncology PLLC- Centennial Medical Center


According to Clinical.Site data, the most researched conditions in "Tennessee Oncology PLLC- Centennial Medical Center" are "Colorectal Cancer" (2 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Stage II Uterine Corpus Cancer AJCC v7" (2 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Tennessee Oncology PLLC- Centennial Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Tennessee Oncology PLLC- Centennial Medical Center


Most popular intervention types in "Tennessee Oncology PLLC- Centennial Medical Center" are "Drug" (17 trials), "Other" (6 trials), "Biological" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Paclitaxel" (3 trials), "oxaliplatin" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Tennessee Oncology PLLC- Centennial Medical Center


The vast majority of trials in "Tennessee Oncology PLLC- Centennial Medical Center" are 13 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Tennessee Oncology PLLC- Centennial Medical Center


Currently, there are NaN active trials in "Tennessee Oncology PLLC- Centennial Medical Center". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tennessee Oncology PLLC- Centennial Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tennessee Oncology PLLC- Centennial Medical Center, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status